Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192337 | SCV000247346 | uncertain significance | not specified | 2015-07-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001371615 | SCV001568186 | uncertain significance | Fanconi anemia | 2024-01-10 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 934 of the FANCD2 protein (p.Ser934Cys). This variant is present in population databases (rs200971205, gnomAD 0.02%). This missense change has been observed in individual(s) with ovarian cancer (PMID: 32546565). ClinVar contains an entry for this variant (Variation ID: 210980). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Sema4, |
RCV001371615 | SCV002529504 | uncertain significance | Fanconi anemia | 2022-02-02 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002492877 | SCV002785418 | uncertain significance | Fanconi anemia complementation group D2 | 2022-02-10 | criteria provided, single submitter | clinical testing |